Respiratory syncytial virus (RSV) can result in an infection that can be severe and life-threatening in high-risk infants. Pediatric clinicians who are up-to-date about risk factors, current recommendations for prevention and management of RSV infection, and strategies for parent counseling can aid parents in effective decision making and help improve outcomes in their pediatric patients.
This activity has been designed to meet the educational needs of pediatricians, pediatric nurse practitioners, pediatric clinical nurse specialists, registered nurses, and pediatric physician assistants.
After taking part in this educational activity, participants should be better able to:
- Describe the incidence, morbidity, and mortality associated with pediatric respiratory syncytial virus (RSV) infection
- Identify infants at risk for severe RSV disease and RSV-associated hospitalization
- Evaluate approaches to RSV prevention and management in pediatric patients, considering current guidelines, to optimize outcomes
- Implement strategies for parent education/counseling regarding RSV infection
- For registered nurses only: Provide appropriate care and counsel for patients and their families
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Haymarket Medical Education. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 0.7 contact hours is provided by Postgraduate Institute for Medicine.
Robert B. Belshe, MD (Chair)
Diane and J. Joseph Adorjan Endowed
Professor of Infectious Diseases and Immunology
Professor of Medicine, Pediatrics, and Molecular Microbiology
Saint Louis University School of Medicine
St Louis, Missouri
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest or a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Robert B. Belshe, MD, hereby states that he is a consultant for Merck & Co. and MedImmune, LLC. Dr. Belshe receives fees for non-CME/CE services from Merck & Co., MedImmune, LLC, and sanofi-aventis.
Concettina Tolomeo, DNP, APRN, FNP-BC, AE-C (CE Reviewer), hereby states that she receives consulting fees from WellTok Inc.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
The following Haymarket Medical Education planners and managers hereby state the following financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months: Mary Jo Krey, Senior Project Editor, Lori Marrese, Senior Program Manager, and Eileen McCaffrey, MS, medical writer, have no real or apparent conflicts of interest to report.
Disclosure of Unlabeled Use
This educational activity may contain discussion of unapproved and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine, MedImmune, LLC, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Institute for Medicine, MedImmune, LLC, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly sponsored by Postgraduate Institute for Medicine and Haymarket Medical Education.
If you have any questions relating to the accreditation of this activity, please contact email@example.com.
This activity is supported by an educational grant from MedImmune, LLC.
There are no fees for participating and receiving CME/CE credit for this activity. During the period October 26, 2012 through October 26, 2013, participants must read the learning objectives and faculty disclosures and study the educational activity.
To obtain credit, a score of 70% or better is required. This CME/CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.